MIPS researchers receive $5 million in latest NHMRC grant round
Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) have received over $5 million in the latest National Health and Medical Research Council (NHMRC) funding round.
Professor Mark Febbraio and Dr David Thal from the Drug Discovery Biology Theme at the Faculty of Pharmacy and Pharmaceutical Sciences have each been awarded NHMRC Investigator Grants, along with 30 researchers from across Monash University.
MIPS has received around $4.5 million for the following projects:
- Using protein structure and dynamics to facilitate drug discovery
- Development of novel therapies to treat obesity related metabolic diseases
Professor Mark Febbraio has received close to $3 million for his project investigating novel therapies to treat obesity related metabolic diseases including diabetes, fatty liver disease and insulin resistance.
Dr David Thal has received over $1.5 million for a five year project exploring using protein structure and dynamics to enable drug discovery techniques.
Former MIPS researcher, Alisa Glukhova (now at the Walter Eliza Hall Institute of Medical Research), also received an NHMRC Investigator Grant for her project looking into the structural basis for targeting WNT signalling pathways in cancer.
For more information on the latest NHMRC grants received by other researchers across Monash University, please see the website here.
For more information about the projects, please visit nhmrc.gov.au.
Contact: Divya Krishnan